GlassScriptPhysician profile
Wen Liou
NPI 1588646509
$2,417.76
in general payments reported to CMS, 2019-2025
16 companies · $232 in 2025
The $232 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $173 · 2021: $435 · 2022: $427 · 2023: $376 · 2024: $540 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $694.57 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Merck Sharp & Dohme LLC | $343.48 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Corium, LLC | $297.49 | 2023-2024 | Azstarys |
| Pfizer INC. | $262.89 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $195.22 | 2019-2024 | Jornay Pm |
| Kaleo, INC. | $123.66 | 2019-2022 | |
| Glaxosmithkline, LLC. | $113.38 | 2019-2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $98.32 | 2021-2024 | Qelbree, Qelbree |
| Sobi, INC | $91.08 | 2019-2022 | |
| Verrica Pharmaceuticals INC. | $46.02 | 2024 | Ycanth |
| Collegium Pharmaceutical, INC. | $39.35 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $30.06 | 2024-2025 | Relexxii |
| Astrazeneca Pharmaceuticals LP | $28.59 | 2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $20.85 | 2024 | |
| Shire North American Group INC | $17.62 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $15.18 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wen Liou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.